Belite Bio, Inc

NASDAQ:BLTE

Biotechnology

Healthcare
$151.02 +0.31%

+$0.46 today

Market cap
$6.08B
Beta
-1.24
P/E (TTM)
-65.9
EPS (TTM)
-$2.26
52W Low $56.10High $200.00

Volume 0.14M

Average 0.17M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$84.21M

FY 2025 · Annual

Net Income

-$77.61M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue00000
Gross Profit00000
Gross Margin—————
Research & Development7.42M8.87M24.84M29.94M45.38M
Selling, General & Admin2.38M3.95M6.82M10.06M38.83M
Operating Expenses9.8M12.82M31.67M40M84.21M
Depreciation & Amortization30K198K399K449K464K
EBITDA(9.64M)(12.43M)(31.2M)(35.67M)(77.15M)
EBITDA Margin—————
Operating Income(9.8M)(12.82M)(31.67M)(40M)(84.21M)
Operating Margin—————
Interest Income5K23K74K3.74M0
Interest Expense016K25K20K0
Other Income / Expenses131K173K45K3.86M6.6M
Income Before Tax(9.67M)(12.65M)(31.62M)(36.14M)(77.61M)
Pre-Tax Margin—————
Income Tax Expense009K6K0
Net Income(9.67M)(12.65M)(31.63M)(36.14M)(77.61M)
Net Margin—————
EPS (Basic)(0.40)(0.63)(1.19)(1.18)(2.31)
EPS (Diluted)(0.40)(0.63)(1.19)(1.18)(2.31)
Weighted Avg Shares24.1M19.98M26.59M30.54M33.54M
Weighted Avg Shares (Diluted)24.1M19.98M26.59M30.54M33.54M

BLTE Earnings Waterfall · TTM

NASDAQ:BLTE · Revenue to Net Income

Key Ratios

EPS$-2.86
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-56.2
P/S Ratio0.0

Analysis

$0 of revenue converted into -$110.9M of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $-2.86, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingNov 12, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
4Statement of changes in beneficial ownershipOct 30, 2026
6-K6-K filingOct 19, 2026

How much revenue does BLTE generate?

Belite Bio, Inc (BLTE) reported $0.00 of revenue in fiscal 2025.

Is BLTE profitable?

Belite Bio, Inc (BLTE) reported -$77.61M of net income.